Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-25-000023

Chief Medical Officer sold 7,000 shares at an average $30.61 ($214,293)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-19 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 5,018 D
2025-12-19 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 8,518 D
2025-12-19 Sale : show line 3 in the form 10b5-1 −641 $28.53 $18,289 7,877 D
2025-12-19 Sale : show line 4 in the form 10b5-1 −1,787 $29.62 $52,935 6,090 D
2025-12-19 Sale : show line 5 in the form 10b5-1 −1,492 $30.70 $45,806 4,598 D
2025-12-19 Sale : show line 6 in the form 10b5-1 −3,080 $31.58 $97,263 1,518 D
Open-market sales · 7,000 sh · avg $30.61 · $214,293

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-19 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 225,063 D
2025-12-19 Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) −3,500 196,492 D
Loading xslF345X05/form4.xml…